Drug resistance of Mycobacterium tuberculosis isolated from patients at a medical center in Taiwan

Chinese Medical Journal (Taipei)

Volumn 60, Issue 1, 1997, Pages 21-27

  Su, Wei Juin ^a,b   Lee, Pui Yuen ^a   Yu, Kwok Woon ^a,b   Perng, Reury Perng ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Drug resistance; Drug susceptibility; Mycobacterium tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; FEMALE; GENERAL HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; TAIWAN;

ADULT; AGE FACTORS; AGED; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0030870609     PISSN: 05781337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Centers for Disease Control. National action plan to combat multidrug-resistant tuberculosis. MMWR Morb Mortal Wkly Rep. 1992;41(RR-11):1-48.
2. Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle 1991;72:1-6.
3. Taiwan Provincial Chronic Disease Control Bureau: the seventh tuberculosis survey in Taiwan (1987-1988). Taipei: Taiwan Provincial Chronic Disease Control Bureau, 1990.
4. Taiwan Provincial Chronic Disease Control Bureau: the eighth tuberculosis survey in Taiwan (1993-1994). Taipei: Taiwan Provincial Chronic Disease Control Bureau, 1996.
5. Bloom BR, Murray JL. Tuberculosis: commentary on a reemergent killer. Science 1992;257:1055-63.
6. Iseman MD, Madsen LA. Drug-resistant tuberculosis. Clin Chest Med 1989;10:341-53.
7. David HL, Fundamentals of drug susceptibility testing in tuberculosis, Atlanta, Centers for Disease Control, PHS, HEW, (HEW publication no. 00-2165), 1971.
8. Vestal, AL. Procedures for the isolation and identification of mycobacteria. Atlanta, GA, Centers for Disease Control, DHEW Publication No.(CDC) 77-8230-115, 1977.
9. Bartmann K. Isoniazid (INH), in Antituberculosis Drugs, Bartmann K., Ed., Springer-Verlag, Berlin, 1988, 113.
10. Suo J, Chang CE, Lin TP, Heifets LB. Minimal inhibitory concentrations of isoniazid, rifampin, ethambutol and streptomycin against M. tuberculosis strains isolated before treatment of patients in Taiwan. Am Rev Respir Dis 1988;138:999-1001.
11. Moulding TS. Should isoniazid be used in retreatment of tuberculosis despite acquired isoniazid resistance? Am Rev Respir Dis 1981;123:262-4.
12. Grandes G, Lopez-De-Munain J, Diaz T, Rullan JV. Drug-resistant tuberculosis in Puerto Rico, 1987-1990. Am Rev Respir Dis 1993;148:6-9.
13. Costello HD, Caras GJ, Snider DE. Drug resistance among previously treated tuberculosis patients, a brief report. Am Rev Respir Dis 1980;121:313-6.
14. Fox W. The chemotherapy of pulmonary tuberculosis: a review. Chest 1979;76:771-82.
15. Iseman MD. Treatment of multidrug-resistant tuberculosis. N Eng J Med 1993;329:784-91.
16. Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons-Florida and New York, 1988-1991. MMWR Morb Mortal Rep. 1991;40:585-91.
17. Heifets L. Qualitative and quantitative drug-susceptibility tests in mycobacteriology. Am Rev Respir Dis 1988;137:1217-22.